Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 The characteristics of the patients

From: Oral aripiprazole in the treatment of tic disorders in China: a cost-effectiveness analysis based on a mapping algorithm derived from a Chinese children and adolescents population

Parameter

Number

Ratio, %

Mean (SD)

Sex

   

 Men

127

86.99

 

 Women

19

13.01

 

Age (years)

146

 

9.01 (2.47)

Height (cm)

143

 

139.05 (14.50)

Weight (kg)

142

 

34.49 (11.92)

Comorbidities

   

  Neuropsychiatric disorders

8

6.16

 

  Other co morbidities

12

8.22

 

YGTSS

   

 YT

145

 

16.24 (8.73)

 YM

145

 

11.28 (5.07)

 YV

145

 

4.95 (6.36)

EQ−5D-Y utility

145

 

0.9312 (0.0832)

  1. Neuropsychiatric disorders, included two of epilepsy, two of attention-deficit/hyperactivity disorder and four of other neuropsychiatric disorders (unknown); Other co morbidities, inclued eight of rhinitis, one of enuresis, three of others (unknown); YT, YGTSS Total scores; YM, YGTSS Motor scales; YV, YGTSS Vocal scales